VMP 36092311000001102

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Cytarabine 2g/20ml solution for injection vials
BNF code 0801030D0AAALAL
Virtual Therapeutic Moiety Cytarabine
Date identifier became valid 31 Oct 2018
Previous product identifier 326844004
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 21 Jan 2009
Previous name Cytarabine 2g/20ml solution for infusion vials
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 20.000
Unit dose form units ml
Unit dose unit of measure vial
Virtual Product Ingredient
Ingredient Cytarabine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninfusion.intravenous
Ontology Drug Form & Route
Form & Route solutioninjection.subcutaneous
Ontology Drug Form & Route
Form & Route solutioninjection.intravenous
Dose Form
Formulation Solution for injection
Drug Route
Route Subcutaneous
Drug Route
Route Intravenous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cytarabine 2g/20ml solution for injection Cytosafe vials (Pfizer Ltd)
Cytarabine 2g/20ml solution for injection vials (Accord-UK Ltd)
Cytarabine 2g/20ml solution for injection vials (Alliance Healthcare (Distribution) Ltd)
Cytarabine 2g/20ml solution for injection vials (Pfizer Ltd)
Virtual Medicinal Product Packs
Cytarabine 2g/20ml solution for injection vials 1 vial

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback